FEMS Microbiology Letters · 1985 · 18 citations · 17 references
PharmacyImmunologyMicrobiologyAntibody EngineeringImmunology Of Infectious DiseasesMonoclonal AntibodiesAntibody CharacterizationAntibody DiscoveryAntibody ScreeningAntibody-antigen RecognitionBacterial ImmunologyHybridoma TechnologyAntibody-mediated Immunity To BacteriaBacterial AntibodiesBacterial Lipopolysaccharide RecognitionEscherichia ColiImmunological IdentificationInhibitor SelectivityLipopolysaccharide-binding Protein
Hybrid cell lines producing monoclonal antibodies with specificity for the lipopolysaccharide (LPS) from the deep rough mutant Salmonella minnesota R595 have been established. Spleen cells from BALB/c mice immunized with live R595 bacteria were fused with Sp 2/0 myeloma cells and three hybridomas producing antibodies specific for heptoseless LPS from Salmonella were selected. All three monoclonal antibodies were shown to bind only to heptoseless, but 3-deoxy-d-manno-octulosonic acid (KDO) containing LPS when tested in enzyme-linked immunosorbent assay (ELISA) against a set of structurally defined LPS and lipid A from Salmonella, Shigella and Escherichia coli. Synthetic KDO was an efficient inhibitor of the antibody-R595 LPS interaction defining that KDO is in an immunodeterminant position interacting with the monoclonal antibodies.
17